Abstract
Introduction
Multiple therapeutic strategies have been proposed for the management of primary cutaneous lymphomas. We report the outcome data and therapeutic response of a group of patients treated with local radiotherapy.
Material and methods
Twenty seven patients with diagnostic of cutaneous lymphoma and treated with local radiation were evaluated for clinical response. Thirteen cases corresponded to cutaneous T-cell lymphomas (CTCL) and 14 to cutaneous B-cell lymphomas (CBCL). Orthovoltage radiotherapy of 100 Kv was used and total dose of radiation ranged from 15 to 30 Gy (mean 24 Gy; median 20 Gy).
Results
The immediate response to the treatment was satisfactory in all cases. In 24 patients (89%) complete response was obtained in the irradiated lesion and in 3 cases (11%) the response was partial. With a mean follow-up of 25.4 months (range 1–100 months) the overall response rate was 96.3%. Fourteen patients (52%) were alive without evidence of disease (6 CTCL and 8 CBCL), 5 patients (18%) retained cutaneous disease or had systemic progression (3 CTCL and 2 CBCL) and 8 patients died (30%). In 7 patients lymphoma progression was the factor leading to death (26%) and in one patient the cause was not related with the disease.
Conclusions
Radiotherapy was demonstrated to be able to induce clinical remission of primary cutaneous lymphomas.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768–85.
Martí RM, Estrach T, Reverter JC, Mascaro JM. Prognostic clinicopathological factors in cutaneous T-cell lymphoma. Arch Dermatol. 1991;127:1511–6.
Zackheim HS, Vonderheid EC, Ramsay DL, LeBoit PE, Rothfleisch J, Kashani-Sabet. Relative frequency of various forms of primary cutaneous lymphomas. J Am Acad Dermatol. 2000;43:795–6.
Wilson LD, Kacinski BM, Jones GW. Local superficial radiotherapy in the management of minimal stage 1A cutaneous T-cell lymphoma (Mycosis fungoides). Int J Radiat Oncol Biol Phys. 1998; 40:109–15.
Micaily B, Miyamoto C, Kantor G, et al. Radiotherapy for unillesional mycosis fugoides. Int J Radiat Oncol Biol Phys. 1998; 2:361–4.
Siegel RS, Pandolfino T, Guitart J, Rosen S, Kuzel TM. Primary cutaneous T-cell lymphoma: review and currents. J Clin Oncol. 2000;5:2908–25.
Wilson LD, Quiros PA, Kolenik SA, et al. Additional courses of total skin electron beam therapy in the treatment of patients with recurrent cutaneous T-cell lymphoma. J Am Acad Dermatol. 1996;35:69–75.
Cotter GW, Bagian RJ, Wasserman TH, Mill W. Palliative radiation treatment of cutaneous mycosis fungoides. A dose response. Int J Radiat Oncol Biol Phys. 1983;9:1477–80.
Lo TC, Salzman FA, Costey GE, Wright KA. Megavolt electron irradiation for localized mycosis fungoides. Acta Radiol Oncol. 1981;20:71–4.
Micaily B, Moser C, Vonderheid EC, et al. The radiation therapy of early stage T-cell lymphoma. Int J Radiat Oncol Biol Phys. 1990;18:1333–9.
Kirova YM, Piedbois Y, Le Bourgeois JP. Radiotherapy in the management of cutaneous B-cells lymphoma. Our experience in 25 cases. Radiotherapy and Oncology. 1999;52:15–8.
Berti E, Alessi E, Caputo R, Gianotti R, Delia D, Vezzoni P. Reticulohistiocytoma of the dorsum. J Am Acad Dermatol. 1988;19: 259–72.
Piccinno R, Caccialanza M, Berti E, Baldini L. Radiotherapy of cutaneous B-cell lymphoma: Our experience in 21 cases. Int J Radiat Oncol Biol Phys. 1993;27: 385–9.
Rijlaarsdam JU, Toonstra J, Meijer OW, Noordijk EM, Willemze R. Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: A clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy. J Clin Oncol. 1996;14:549–55.
Santucci M, Pimpinelli N, Arganini L. Primary cutaneous B-cell lymphoma: a unique type of low-grade lymphoma. Cancer. 1991;67:2311–26.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Conill, C., Navalpotro, B., López, I. et al. Results of radiotherapy in primary cutaneous lymphoma. Clin Transl Oncol 8, 430–434 (2006). https://doi.org/10.1007/s12094-006-0197-3
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s12094-006-0197-3